DEHYDROXYMETHYLEPOXYQUINOMICIN
- CAS No.
- 287194-40-5
- Chemical Name:
- DEHYDROXYMETHYLEPOXYQUINOMICIN
- Synonyms
- DHMEQ;DHM2EQ;()DHMEQ,( ) DHMEQ;DEHYDROXYMETHYLEPOXYQUINOMICIN;Dehydroxymethylepoxyquinomicin (DHMEQ);(-)-DHMEQ?(dehydroxymethylepoxyquinomicin);2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzaMide;Benzamide, 2-hydroxy-N-[(1S,2S,6S)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]-;2-hydroxy-N-[(1aS,2S,5aS)-2-hydroxy-5-oxo-1a,2,5,5a-tetrahydrocyclohexa[1,2-b]oxiren-3-yl]benzamide
- CBNumber:
- CB8419477
- Molecular Formula:
- C13H11NO5
- Molecular Weight:
- 261.23
- MDL Number:
- MFCD11100254
- MOL File:
- 287194-40-5.mol
Product description | Number | Pack Size | Price |
(-)-DHMEQ 98.83% | CS-5488 | 2mg | $168 |
(-)-DHMEQ 98.83% | CS-5488 | 5mg | $264 |
(-)-DHMEQ 98.83% | CS-5488 | 10mg | $360 |
DHMEQ 95.00% | INB0001467 | 5MG | $496.86 |
(-)-DHMEQ 98.83% | CS-5488 | 25mg | $720 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
DEHYDROXYMETHYLEPOXYQUINOMICIN price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-5488 | (-)-DHMEQ 98.83% | 287194-40-5 | 2mg | $168 | 2021-12-16 | Buy |
ChemScene | CS-5488 | (-)-DHMEQ 98.83% | 287194-40-5 | 5mg | $264 | 2021-12-16 | Buy |
ChemScene | CS-5488 | (-)-DHMEQ 98.83% | 287194-40-5 | 10mg | $360 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | INB0001467 | DHMEQ 95.00% | 287194-40-5 | 5MG | $496.86 | 2021-12-16 | Buy |
ChemScene | CS-5488 | (-)-DHMEQ 98.83% | 287194-40-5 | 25mg | $720 | 2021-12-16 | Buy |
DEHYDROXYMETHYLEPOXYQUINOMICIN Chemical Properties,Uses,Production
Uses
(-)-DHMEQ (Dehydroxymethylepoxyquinomicin) is a potent, selective and irreversible NF-κB inhibitor that covalently binds to a cysteine residue. (-)-DHMEQ inhibits nuclear translocation of NF-κB and shows anti-inflammatory and anticancer activity[1][2][3].
in vivo
(-)-DHMEQ (4 mg/kg or 12 mg/kg; intraperitoneal injection; on day 0 and 3 times a week; for one month; SCID mice) treatment shows a significant increase in the survival rate in mice[2].
Animal Model: | Male C.B17-scid/scid (5 weeks old) mice injected with MT-2 cells[2] |
Dosage: | 4 mg/kg or 12 mg/kg |
Administration: | Intraperitoneal injection; on day 0 and 3 times a week; for one month |
Result: | Showed a significant increase in the survival rate in mice. |
IC 50
RelA; RelB
References
[1] Yinzhi Lin, et al. Inhibition of Late and Early Phases of Cancer Metastasis by the NF-κB Inhibitor DHMEQ Derived from Microbial Bioactive Metabolite Epoxyquinomicin: A Review. DOI:10.3390/ijms19030729
[2] Mariko Watanabe, et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005 Oct 1;106(7):2462-71. DOI:10.1182/blood-2004-09-3646
[3] Quach HT, et al. Eudesmane-Type Sesquiterpene Lactones Inhibit Nuclear Translocation of the Nuclear Factor κB Subunit RelB in Response to a Lymphotoxin β Stimulation. Biol Pharm Bull. 2017;40(10):1669-1677. DOI:10.1248/bpb.b17-00170
DEHYDROXYMETHYLEPOXYQUINOMICIN Preparation Products And Raw materials
Raw materials
Preparation Products
DEHYDROXYMETHYLEPOXYQUINOMICIN Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Alchem Pharmtech,Inc. | 8485655694 | sales@alchempharmtech.com | United States | 63687 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32434 | 58 |
HANGZHOU LEAP CHEM CO., LTD. | +86-571-87711850 | market18@leapchem.com | China | 43339 | 58 |
Shanxi Tihondan Pharmaceutical Technology Co., Ltd | +8618235132063 | sales@tihondan.com | China | 3767 | 58 |
Aladdin Scientific | tp@aladdinsci.com | United States | 52924 | 58 | |
Amadis Chemical Company Limited | 571-89925085 | sales@amadischem.com | China | 131957 | 58 |
Chembest Research Laboratories Limited | +86-21-20908456 | sales@BioChemBest.com | China | 6003 | 61 |
Haoyuan Chemexpress Co., Ltd. | 021-58950125 | info@chemexpress.com | China | 7552 | 61 |
ShangHai Caerulum Pharma Discovery Co., Ltd. | 18149758185 | sales-cpd@caerulumpharma.com | China | 3504 | 58 |
Shanghai HuanChuan Industry Co.,Ltd. | 021-61478794 | sales@hcshhai.com | China | 9793 | 50 |